Announced Tue, 30 Jun · 17:48 IST
Trading Window Closure Ahead of Q1 FY27 Results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-11.8%1-day move
₹6.80
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-11.8-11.8-11.8-15.7-17.4-14.6-20.3———
Up moveDown movePending
AI summary
Dipna Pharmachem has closed its trading window for all directors, promoters, designated persons, and insiders from July 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The intimation has been made under SEBI Insider Trading Regulations. Signed by Managing Director Keyur Dipakkumar Shah. This is a routine compliance filing with no financial details or corporate action disclosed.
Likely market impact
Routine compliance filing. No material impact on shareholders. Indicates upcoming Q1 FY27 results announcement in coming weeks.